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positive defects are mainly observed in the inferoposte-
rior, inferior, and apical myocardium, which could be ex-
plained by differences in regional blood flow during ven-
tricular pacing  [4] . Importantly, these perfusion abnor - 
malities are more prominent during physical exercise 
compared with pharmacological stress using dipyridam-
ole or adenosine  [5] .
 Stress echocardiography is usually performed using 
pharmacological stressors such as dobutamine or dipyri-
damol. Dobutamine stress echocardiography has been 
extensively studied in patients undergoing noncardiac 
surgery  [7] . Through the infusion of dobutamine, posi-
tive chronotropic and inotropic effects increase myocar-
dial oxygen consumption. In pacemaker-dependent pa-
tients, wall motion abnormalities are present because of 
an altered ventricular activation; consequently, the inter-
pretation of dobutamine stress echocardiography can be 
misleading. Furthermore, Ciaroni et al.  [8] suggested that 
the presence of chronotropic incompetence may reduce 
the accuracy of dobutamine stress echocardiography.
 Pacing stress echocardiography (PASE) using atrial 
pacing through the esophagus has been successfully used 
since the 1980s for the detection and risk stratification of 
CAD  [9] . Importantly, in contrast to dobutamine stress 
echocardiography, PASE only has positive chronotropic 
effects and no inotropic effects. Modi et al.  [10] summa-
 Cardiac pacing has been used in the treatment of 
bradyarrhythmia for more than 50 years, and through -
 out that time period both clinical practice and an impres-
sive amount of research have objectively proven its effec-
tiveness. Especially in the last decade the number of pa-
tients treated with a permanent pacemaker implantation 
has increased, and due to the aging of the population this 
number continue to grow  [1] . Importantly, the prevalence 
of coronary artery disease (CAD) in these patients is high 
and most patients will develop symptoms suggestive of 
angina pectoris. As a consequence, the use of noninvasive 
testing has increased in these vulnerable subjects to pre-
vent additional invasive assessment or intervention. Non-
invasive methods for the detection and diagnosis of CAD 
in patients with a permanent pacemaker, recommended 
by the American College of Cardiology/American Heart 
Association (ACC/AHA) guidelines, include adenosine 
or dipyridamole perfusion imaging and dobutamine 
stress echocardiography  [2] . However, in the last decade 
studies have demonstrated pitfalls and weaknesses of 
these imaging modalities in patients with a permanent 
pacemaker  [3–6] . Single-photon emission computed to-
mography (SPECT) with either thallium or technetium is 
routinely used for ischemia detection, but in patients with 
a pacemaker perfusion defects that were not related to 
obstructive CAD have been demonstrated  [3, 6] . False-
 Received and accepted: June 11, 2010
 Published online: August 7, 2010
 
 
 Don Poldermans, MD
 Department of Vascular Surgery, Erasmus Medical Center
 ‘s-Gravendijkwal 230, room H805
 NL–3015 CE Rotterdam (The Netherlands)
 Tel. +31 10 703 4613, Fax +31 10 703 4957, E-Mail d.poldermans   @   erasmusmc.nl 
 © 2010 S. Karger AG, Basel
 0008–6312/10/1163–0226$26.00/0 
 Accessible online at:
 www.karger.com/crd 
 Detection of CAD in Patients with a 
Permanent Pacemaker 
Cardiology 2010;116:226–228 227
rized studies on PASE and reported a sensitivity between 
79 and 95% and a specificity between 71 and 100%. In ad-
dition, they observed an accuracy of 90% for PASE in the 
detection of CAD compared with standard coronary an-
giography. Recently, a novel method for cardiac pacing 
was introduced which uses PASE with a permanent pace-
maker.
 In this issue of  Cardiology , Shimoni et al.  [11] describe 
the results of their study in which an evaluation was made 
between the diagnostic accuracy of PASE compared with 
dypiridamol thallium-201 SPECT. A group of 58 patients 
with a permanent pacemaker and known or suspected 
CAD was studied. Both PASE and SPECT were per-
formed in 53 (91%) patients, and the concordance in 
terms of a positive test result was 75%, with a   value of 
0.64. The sensitivity and specificity of PASE were 87 and 
78% compared with 96 and 57% for SPECT. Before the 
present study, several small single-center studies tested 
the ability of PASE for the detection of CAD  [12–14] . A 
comparison between these studies has limitations, as 
none of them used the same stress and pacing protocols. 
Overall, the sensitivity and specificity of PASE ranged 
from 77 to 96 and from 68 to 88%, respectively, depend-
ing on gender and age  [14] . The authors observed a con-
cordance of 75% (  = 0.64) between PASE and SPECT in 
detecting CAD. A   value between 0.61 and 0.80 means 
that there is substantial concordance between the 2 tests.
 In addition to the testing results, Shimoni et al.  [11] 
described the prognostic value of PASE in patients with a 
permanent pacemaker. During a widely distributed fol-
low-up period of 51 months (range 3–68 months), 8 car-
diac deaths occurred and 24 cardiac events were ob-
served. Multivariate regression analyses showed that only 
positive PASE was associated with the occurrence of car-
diac events. Although these results seem to be in line with 
previous results of larger studies  [14, 15] , they need to be 
interpreted with caution due to the limited number of 
patients and cardiac events in the present study.
 In summary, Shimoni et al.  [11] describe the value of a 
novel noninvasive technique in the cardiac evaluation of 
elderly patients with a permanent pacemaker. Compared 
with SPECT, the use of PASE has acceptable sensitivity 
and specificity for the detection of CAD in these patients. 
Although the concordance between PASE and SPECT re-
garding a positive test result is substantial, it is important 
to acknowledge the fact that PASE and SPECT are intrin-
sically different techniques. Whereas in SPECT myocar-
dial perfusion is studied, PACE is directed at wall motion 
abnormalities. Expected advantages of PASE are that it is 
cost-effective, radiation-free, and less time-consuming 
than SPECT. Major limitations of the present study in-
clude: (1) a nonrandomized design, (2) PASE and SPECT 
were not both performed in all patients, and (3) coronary 
angiography was not routinely performed. In conclusion, 
this study demonstrated that PASE is a promising nov-
elty for detecting ischemia in pacemaker-dependent pa-
tients, but further evaluation is required in prospective, 
randomized, comparative studies.
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